PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Cambridge, UK. js44@sanger.ac.uk.\', \'Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.\', \'Cell Surface Signalling Laboratory, Wellcome Sanger Institute, Cambridge, UK. gw2@sanger.ac.uk.\', \'Department of Biology, York Biomedical Research Institute, Hull York Medical School, University of York, Wentworth Way, York, UK. gw2@sanger.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-020-80464-1
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33432067
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33432067>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33432067>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all